Table 1 Baseline characteristics of patients with chronic CSC in this study. Values are presented as mean ± SD.

From: Clinical features of pachyvessels associated with polypoidal choroidal vasculopathy in chronic central serous chorioretinopathy

 

Group

P

without PCV formation (n = 36)

Subsequent PCV formation (n = 18)

Male sex, no. (%)

32 (88.9%)

15 (83.3%)

0.674*

Age (years)

45.4 ± 10.8

44.9 ± 7.9

0.862†

Refractive error (S.E.)

− 0.3 ± 1.7

− 0.8 ± 1.8

0.796‡

LogMAR BCVA

 Initial

0.10 ± 0.12

0.17 ± 0.21

0.088‡

 SRF resolved

0.03 ± 0.06

0.09 ± 0.08

0.001‡

SFCT (μm)

320.1 ± 92.4

325.3 ± 142.1

0.851‡

CSC recurrence, no. (%)

12 (33.3%)

8 (44.4%)

0.425**

Presence of pachyvessels, no. (%)

9 (25.0%)

12 (66.7%)

0.003**

Follow-up duration (months)

70.8 ± 39.7

77.9 ± 26.5

0.236‡

  1. P value < 0.05 was considered statistically significant. *Fisher's exact test; †independent t test; ‡Mann–Whitney test;
  2. **Chi-square test; CSC, central serous chorioretinopathy; PCV, polypoidal choroidal vasculopathy; S.E., spherical equivalent; logMAR, logarithm of the minimal angle of resolution; SRF, subretinal fluid; SFCT, subfoveal choroidal thickness.
Back to article page